Hans Edgar Bishop, CEO & President at Juno Therapeutics, Inc. (JUNO), sold 230,500 shares at $39.18 ($8.9M) on 2016-06-30, disclosed to the SEC on 2016-09-02.
Open-market sale of $8.9M JUNO by CEO & President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.41 | 108,894 | $4.2M | 47.2% |
| 2 | $38.41 | 108,894 | $4.2M | 47.2% |
| 3 | $39.18 | 6,356 | $249K | 2.8% |
| 4 | $39.18 | 6,356 | $249K | 2.8% |
| Total | $38.45 avg | 230,500 | $8.9M | 100% |
| Filing → |
| JUNO | SELL | 2016-09-21 | $4.9M | — | Filing → |
| JUNO | SELL | 2016-09-09 | $1.4M | — | Filing → |
| JUNO | SELL | 2016-09-02 | $2.6M | — | Filing → |